<DOC>
	<DOCNO>NCT02193620</DOCNO>
	<brief_summary>The purpose study ass effectiveness , safety pharmacokinetics Oral Nalbuphine treatment postoperative pain follow hemorrhoidectomy .</brief_summary>
	<brief_title>Study PHN131 Patients After Surgery</brief_title>
	<detailed_description>• Primary Efficacy Endpoint : Pain assessment calculate area curve VAS pain intensity score 48 hour . • Secondary Efficacy Endpoints : 1 . Consumption diclofenac ( Day 1-2 ) via Intramuscular Injection ( IM injection ) . 2 . Time end operation first IM injection diclofenac dose 3 . Brief Pain Inventory ( BPI ) . 4 . Patient satisfaction .</detailed_description>
	<mesh_term>Nalbuphine</mesh_term>
	<criteria>1 . Male female &gt; = 20 year age Screening 2 . Scheduled electively undergo 2 3column excisional hemorrhoidectomy 3 . American Society Anesthesiology Physical Class 1 3 4 . Clinical lab value twice upper limit normal ( value potential clinical concern detail Appendix ) , abnormal , deem clinically significant per Investigator . 5 . Ability willingness provide inform consent , adhere study visit schedule complete study assessment language specific questionnaire . 1 . Body weight less 40 kg . 2 . Concurrent fissurectomy . 3 . Subject pregnant breastfeeding . Women childbearing potential must negative urine pregnancy test Baseline . 4 . Women childbearing potential disagree use acceptable method contraception ( e.g. , hormonal contraceptive , IUD , barrier device abstinence ) throughout study . 5 . History hypersensitivity allergy amidetype local anesthetic , opioid , ingredient medication administer study . 6 . Subject rest respiratory rate le 8 per minute blood oxygen saturation le 90 mmHg . 7 . Use NSAIDs , selective COX2 inhibitor , opioid , acetaminophen , selective serotonin reuptake inhibitor ( SSRI ) , tricyclic antidepressant ( TCA ) , gabapentin , pregabalin within three day surgery . 8 . Chronic use opioid medication 14 day last 3 month , nonopioid pain medication 5 time per week . 9 . Use longacting opioid medication within 3 day surgery opioid medication within 24 hour surgery . 10 . Current painful physical condition concurrent surgery require analgesic treatment postoperative period . 11 . Contraindication epinephrine paincontrol agent plan postoperative use . 12 . Administration investigational drug within long 30 day 5 elimination halflives investigational drug prior study drug administration . 13 . Any psychiatric disorder , psychological , medical , laboratory condition may interfere study assessment compliance . 14 . Significant medical condition laboratory result may indicate increase vulnerability study drug procedure , thus expose subject unreasonable risk result participate clinical trial . 15 . Any clinically significant event condition uncover surgery . 16 . History abuse illicit drug , prescription medicine alcohol within past 2 year . 17 . Known history antiHIV antibody positive . 18 . Failure pass drug alcohol screen .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Analgesic</keyword>
	<keyword>Narcotics</keyword>
	<keyword>Opioids</keyword>
	<keyword>Pain relief surgery</keyword>
</DOC>